Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cell Pharma is a Mexico-based specialty pharmaceutical company focused on commercializing high-specialty products in wound care, scar management, fibrosis, dermatology, antisepsis, and liver disease diagnostics. Its marketed portfolio includes KitosCell-Q for wound management, KitosCell Gel PFD and Kitocream for scar care, KitosCell-LP, a prolonged-release pirfenidone product for pulmonary and hepatic fibrosis, Zaxcell Gel and TriClean for acne-related care, Accua Aséptic antiseptic solution, and NASH-FibroTest for liver assessment. The company presents itself as an innovation- and R&D-driven pharmaceutical business and operates a digital medical-scientific library aimed at healthcare professionals. Publicly available information points to an operating commercial-stage company rather than a venture-backed clinical biotech with a disclosed multi-asset development pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cell Pharma.